Associated Papers
Efavirenz pharmacogenetics in a cohort of Italian patients.
Cusato J et al.
International Journal of Antimicrobial Agents, 2016
Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B et al.
Gene, 2013
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA et al.
European Journal of Clinical Pharmacology, 2003
Select a paper to view details